GlucoTrack, Inc.
GCTK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $166,467 | $290,265 | $1,302,840 | $3,853,080 |
| - Cash | $5,617 | $4,492 | $2,312 | $6,062 |
| + Debt | $267 | $196 | $195 | $250 |
| Enterprise Value | $161,117 | $285,969 | $1,300,723 | $3,847,268 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$36 | -$13 | -$23 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$21,978 | -$7,084 | -$4,412 | -$3,939 |
| % Margin | – | – | – | – |
| Net Income | -$22,597 | -$7,097 | -$4,435 | -$4,067 |
| % Margin | – | – | – | – |
| EPS Diluted | 60.76 | -38.3 | -28.66 | -26.32 |
| % Growth | 258.6% | -33.6% | -8.9% | – |
| Operating Cash Flow | -$12,490 | -$6,558 | -$3,729 | -$3,769 |
| Capital Expenditures | -$104 | $0 | -$1 | -$5 |
| Free Cash Flow | -$12,594 | -$6,558 | -$3,730 | -$3,774 |